STRS Ohio’s ImmunityBio IBRX Stock Holding History

STRS Ohio’s Portfolio IBRX Stock Details IBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$40.6K	Buy	+4,300	New	+$34.4K	﹤0.01%	2078
2022 Q3	–	Sell	-10,600	Closed	-$39K	–	2040
2022 Q2	$39K	Sell	10,600 -4,900	-32%	-$19.7K	﹤0.01%	1894
2022 Q1	$86K	Hold	15,500	–	–	﹤0.01%	1871
2021 Q4	$94K	Hold	15,500	–	–	﹤0.01%	1908
2021 Q3	$150K	Hold	15,500	–	–	﹤0.01%	1859
2021 Q2	$221K	Buy	15,500 +7,900	+104%	+$131K	﹤0.01%	1787
2021 Q1	$180K	Buy	+7,600	New	+$197K	﹤0.01%	1814
2020 Q4	–	Sell	-7,500	Closed	-$52K	–	2211
2020 Q3	$52K	Buy	7,500 +1,300	+21%	+$13K	﹤0.01%	1963
2020 Q2	$76K	Buy	+6,200	New	+$35K	﹤0.01%	1843
2015 Q4	–	Sell	-2,200	Closed	-$25K	–	1934
2015 Q3	$25K	Buy	+2,200	New	+$48K	﹤0.01%	1806

Other funds holding IBRX

SEB Asset Management Stockholm $27B AUM

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Allen Holding New York $1.15B AUM 24.01% 1-Year Est. Return

Kercheville Advisors San Antonio, Texas $361M AUM 57.53% 1-Year Est. Return

D.A. Davidson & Co Great Falls, Montana $18.6B AUM 17.65% 1-Year Est. Return

Sheets Smith Wealth Management Winston-Salem, North Carolina $958M AUM 21.88% 1-Year Est. Return

State of Michigan Retirement System Lansing, Michigan $22.6B AUM 32.98% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

STRS Ohio's IBRX Position: Q3 2026 in Review

STRS Ohio opened a new position in ImmunityBio (IBRX) in Q3 2026: 4,300 shares worth $40.6K. The stake represents ﹤0.01% of the portfolio and ranks #2078 among its holdings. This is a return to the name: STRS Ohio previously reported a position in IBRX as recently as Q2 2022.

STRS Ohio first reported a position in IBRX in Q3 2015 and has held it in 10 quarters since. The position peaked at $221K in Q2 2021. 174 funds tracked by Wall St. Rank hold IBRX as of Q3 2026.

STRS Ohio held 4,300 shares of ImmunityBio worth $40.6K as of Q3 2026.
ImmunityBio was a new STRS Ohio position in Q3 2026.
ImmunityBio made up ﹤0.01% of STRS Ohio's portfolio in Q3 2026, its #2078 holding.
STRS Ohio first reported a position in ImmunityBio in Q3 2015 and has held it in 10 quarters since.
STRS Ohio's ImmunityBio position peaked at $221K in Q2 2021.
174 funds tracked by Wall St. Rank held ImmunityBio as of Q3 2026.

Based on STRS Ohio's 13F filing for Q3 2026, filed 30 Oct 2026.